Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 111Neoplasms 22Neoplasm Metastasis 17Brain Neoplasms 15Breast Neoplasms, Male 13Head and Neck Neoplasms 7Squamous Cell Carcinoma of Head and Neck 6Stomach Neoplasms 5Glioblastoma 5Colorectal Neoplasms 5Prostatic Neoplasms 4Ovarian Neoplasms 4Inflammatory Breast Neoplasms 4Carcinoma, Ovarian Epithelial 4Salivary Gland Neoplasms 3Lung Neoplasms 3Gliosarcoma 3Glioma 3Ependymoma 3Carcinoma, Non-Small-Cell Lung 3Urinary Bladder Neoplasms 2Unspecified Adult Solid Tumor, Protocol Specific 2Solid Tumors 2Recurrence 2Osteitis Deformans 2Oligodendroglioma 2Neuroma, Acoustic 2Neurofibromatosis 2 2Gallbladder Neoplasms 2Esophageal Neoplasms 2

Interventions

Surveys and Questionnaires 3pazopanib 2Oxaliplatin 2Erlotinib Hydrochloride 2Cetuximab 2Bevacizumab 2satraplatin 1ixazomib 1Vorinostat 1Videotape Recording 1Valproic Acid 1Trastuzumab 1Platinum 1Leucovorin 1Lapatinib 1LY 2275796 1Fluorouracil 1Everolimus 1Capecitabine 1Azacitidine 1Albumin-Bound Paclitaxel 110-propargyl-10-deazaaminopterin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Advanced Cancers × Lapatinib × Clear all
NCT01454804 2016-04-13

Pazopanib, Lapatinib or Trastuzumab in Subjects With Solid Tumors

M.D. Anderson Cancer Center

Phase 1 Completed
43 enrolled

Advanced Cancers

Data powered by HemOnc (CC BY 4.0) Colophon âš¡